Published in J Virol on November 01, 1991
Arterivirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulating sequences. Proc Natl Acad Sci U S A (1999) 2.42
Identification and characterization of a coronavirus packaging signal. J Virol (1992) 2.01
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89
Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J Virol (1994) 1.85
Viral replicase gene products suffice for coronavirus discontinuous transcription. J Virol (2001) 1.79
Genetics of mouse hepatitis virus transcription: evidence that subgenomic negative strands are functional templates. J Virol (1994) 1.72
Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J Virol (1993) 1.71
Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc Natl Acad Sci U S A (1997) 1.70
A cis-acting function for the coronavirus leader in defective interfering RNA replication. J Virol (1994) 1.68
Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implications for the role of minus-strand RNA in RNA replication and transcription. J Virol (1994) 1.64
Mechanism of coronavirus transcription: duration of primary transcription initiation activity and effects of subgenomic RNA transcription on RNA replication. J Virol (1992) 1.61
Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. J Virol (1994) 1.58
Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging. J Virol (2001) 1.56
The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations. J Virol (1992) 1.49
Subgenomic negative-strand RNA function during mouse hepatitis virus infection. J Virol (2000) 1.48
Mutagenic analysis of the coronavirus intergenic consensus sequence. J Virol (1992) 1.45
Effect of intergenic consensus sequence flanking sequences on coronavirus transcription. J Virol (1993) 1.44
Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J Virol (1994) 1.41
Regulation of coronavirus mRNA transcription. J Virol (1995) 1.40
Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J (2000) 1.38
Transcription regulatory sequences and mRNA expression levels in the coronavirus transmissible gastroenteritis virus. J Virol (2002) 1.38
Characterization of a murine coronavirus defective interfering RNA internal cis-acting replication signal. J Virol (1995) 1.36
Discontinuous and non-discontinuous subgenomic RNA transcription in a nidovirus. EMBO J (2002) 1.32
Polypyrimidine tract-binding protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription. J Virol (1999) 1.28
Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells. J Virol (2002) 1.27
Investigation of the control of coronavirus subgenomic mRNA transcription by using T7-generated negative-sense RNA transcripts. J Virol (1995) 1.26
Engineering the transmissible gastroenteritis virus genome as an expression vector inducing lactogenic immunity. J Virol (2003) 1.25
Translation but not the encoded sequence is essential for the efficient propagation of the defective interfering RNAs of the coronavirus mouse hepatitis virus. J Virol (1995) 1.25
Coronaviruses as vectors: position dependence of foreign gene expression. J Virol (2003) 1.25
Characterization of an equine arteritis virus replicase mutant defective in subgenomic mRNA synthesis. J Virol (1999) 1.22
RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells. J Virol (2000) 1.22
Interactions between the cytoplasmic proteins and the intergenic (promoter) sequence of mouse hepatitis virus RNA: correlation with the amounts of subgenomic mRNA transcribed. J Virol (1995) 1.21
Evidence for coronavirus discontinuous transcription. J Virol (1994) 1.20
Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. J Virol (2003) 1.19
Insertion of a new transcriptional unit into the genome of mouse hepatitis virus. J Virol (1999) 1.19
Stem-loop III in the 5' untranslated region is a cis-acting element in bovine coronavirus defective interfering RNA replication. J Virol (2003) 1.18
Assembled coronavirus from complementation of two defective interfering RNAs. J Virol (1997) 1.18
The 3' untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA. J Virol (1996) 1.14
Genetic manipulation of arterivirus alternative mRNA leader-body junction sites reveals tight regulation of structural protein expression. J Virol (2000) 1.13
The effect of two closely inserted transcription consensus sequences on coronavirus transcription. J Virol (1995) 1.13
Murine coronavirus packaging signal confers packaging to nonviral RNA. J Virol (1997) 1.13
Polypyrimidine tract-binding protein binds to the complementary strand of the mouse hepatitis virus 3' untranslated region, thereby altering RNA conformation. J Virol (1999) 1.10
Coronavirus mRNA transcription: UV light transcriptional mapping studies suggest an early requirement for a genomic-length template. J Virol (1992) 1.07
Emergence of pathogenic coronaviruses in cats by homologous recombination between feline and canine coronaviruses. PLoS One (2014) 1.05
Importance of the positive-strand RNA secondary structure of a murine coronavirus defective interfering RNA internal replication signal in positive-strand RNA synthesis. J Virol (1998) 1.02
Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase. J Virol (2004) 1.01
Coronaviruses as vectors: stability of foreign gene expression. J Virol (2005) 0.99
SYNCRIP, a member of the heterogeneous nuclear ribonucleoprotein family, is involved in mouse hepatitis virus RNA synthesis. J Virol (2004) 0.97
Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis. J Virol (2003) 0.96
Coronavirus transcription early in infection. J Virol (1998) 0.95
Two murine coronavirus genes suffice for viral RNA synthesis. J Virol (1995) 0.93
Subgenomic messenger RNA amplification in coronaviruses. Proc Natl Acad Sci U S A (2010) 0.89
The leader RNA of coronavirus mouse hepatitis virus contains an enhancer-like element for subgenomic mRNA transcription. J Virol (2000) 0.89
Replication of murine coronavirus defective interfering RNA from negative-strand transcripts. J Virol (1996) 0.87
The structure and functions of coronavirus genomic 3' and 5' ends. Virus Res (2015) 0.87
Torovirus non-discontinuous transcription: mutational analysis of a subgenomic mRNA promoter. J Virol (2005) 0.82
Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci U S A (1977) 41.76
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A (1987) 18.91
3'-terminal nucleotide sequence of encephalomyocarditis virus RNA determined by reverse transcriptase and chain-terminating inhibitors. Proc Natl Acad Sci U S A (1978) 6.67
RNA of mouse hepatitis virus. J Virol (1978) 4.27
Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J Virol (1990) 4.19
The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology (1991) 4.07
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J Virol (1980) 3.82
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc Natl Acad Sci U S A (1989) 3.65
The virus-specific intracellular RNA species of two murine coronaviruses: MHV-a59 and MHV-JHM. Virology (1981) 3.57
Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Gesamte Virusforsch (1974) 3.24
Coronavirus: organization, replication and expression of genome. Annu Rev Microbiol (1990) 3.20
Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06
Evidence for specificity in the encapsidation of Sindbis virus RNAs. J Virol (1989) 2.91
Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol (1982) 2.86
Minus-strand copies of replicating coronavirus mRNAs contain antileaders. J Virol (1991) 2.27
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J Virol (1991) 2.14
Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13
Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J Virol (1985) 2.10
Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07
Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07
High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95
Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89
Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J Virol (1990) 1.88
Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology (1988) 1.87
Coronavirus JHM: nucleotide sequence of the mRNA that encodes nucleocapsid protein. Nucleic Acids Res (1983) 1.82
Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol (1989) 1.77
Defective interfering particles of mouse hepatitis virus. Virology (1984) 1.76
Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J Virol (1988) 1.76
Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs. Virology (1988) 1.73
An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J (1990) 1.69
Evolution of the 5'-end of genomic RNA of murine coronaviruses during passages in vitro. Virology (1989) 1.43
Biosynthesis, structure, and biological activities of envelope protein gp65 of murine coronavirus. Virology (1989) 1.19
Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity (1996) 4.68
Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol (2007) 1.82
Effect of intergenic consensus sequence flanking sequences on coronavirus transcription. J Virol (1993) 1.44
Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol (2001) 1.27
Murine coronavirus packaging signal confers packaging to nonviral RNA. J Virol (1997) 1.13
Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages. Exp Cell Res (2010) 0.86
Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma. Oncol Rep (2000) 0.83
Conditional regulation of cyclooxygenase-2 in tracheobronchial epithelial cells modulates pulmonary immunity. Clin Exp Immunol (2007) 0.81
Localized gastric crystal-storing histiocytosis. Histopathology (2007) 0.80
Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence. Arch Immunol Ther Exp (Warsz) (2001) 0.80
A case of endobronchial actinomycosis. Korean J Intern Med (2000) 0.77
Multicentric telangiectatic osteosarcoma. Pathol Int (2001) 0.76
FNA cytology of subcutaneous panniculitis-like T-cell lymphoma with granulomas: a diagnostic pitfall. Cytopathology (2011) 0.75
An angiographic lesion mimicking pseudo-aneurysm in cerebral arteriovenous malformation. Acta Neurochir (Wien) (2001) 0.75
Numerical determination of a true absorption spectrum from grazing-incidence fluorescence EXAFS data. J Synchrotron Radiat (1999) 0.75
Large cystic glioblastoma multiforme. Clin Neuroradiol (2013) 0.75